(Q35062402)

6 August 2017

1 reference

title

Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors (English)

1 reference

6 August 2017

Barter PJ

1

1 reference

6 August 2017

publication date

1 December 2002

1 reference

Atherosclerosis. Supplements

6 August 2017

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

39-47

1 reference

Remodelling of high density lipoproteins by plasma factors

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Characterization of human high-density lipoproteins by gradient gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Isolation and partial characterization of lipoprotein A-II (LP-A-II) particles of human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Transfers and exchanges of esterified cholesterol between plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

The influence of apolipoproteins on the hepatic lipase-mediated hydrolysis of high density lipoprotein phospholipid and triacylglycerol

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Cholesterol transport between cells and high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Remodeling of HDL by phospholipid transfer protein: demonstration of particle fusion by 1H NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

The influence of cholesteryl ester transfer protein on the composition, size, and structure of spherical, reconstituted high density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithinchoesteryl acyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Cholesteryl ester transfer protein, high density lipoprotein and arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Effect of Antisense Oligonucleotides against Cholesteryl Ester Transfer Protein on the Development of Atherosclerosis in Cholesterol-fed Rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

A Low Prevalence of Coronary Heart Disease among Subjects with Increased High-Density Lipoprotein Cholesterol Levels, Including Those with Plasma Cholesteryl Ester Transfer Protein Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2802%2900041-7

7 January 2021

10.1016/S1567-5688(02)00041-7

Identifiers

DOI

1 reference

6 August 2017

1 reference